Clinical trials: Masseter Muscle Hypertrophy
Masseter Muscle Hypertrophy
MEDITOXIN® Treatment in Subject With Benign Masseteric Hypertrophy
To evaluate the efficacy and safety of MEDITOXIN in subjects with benign masseteric hypertrophy compared with placebo
- Trial name
- NCT03452345
- Testing
- Meditoxin
- Where
- South Korea
- Volunteers
- 180 people
- Sponsor
- Medy-Tox
Masseter Muscle Hypertrophy
Botulinum Toxin Type A (BOTOX®) Treatment of Masseter Muscle Hypertrophy
This study will evaluate the safety and efficacy of a range of doses of botulinum toxin Type A (BOTOX®) for the treatment of patients with bilateral Masseter Muscle Hypertrophy (MMH).
- Trial name
- NCT02010775
- Testing
- botulinum toxin Type A, Normal saline
- Where
- 14 sites in Australia, Canada and 1 more
- Volunteers
- 187 people
- Sponsor
- Allergan
Hypertrophy of Masseter Muscle
Medytoxin® Treatment in Patients With Benign Masseteric Hypertrophy
This study design is A Randomized, Double-blind, Multi-center, Phase II Optimal Dose-finding Study to Determine the Safety and Efficacy of Meditoxin® in Subjects in Benign Masseteric Hypertrophy.
- Trial name
- NCT02292472
- Testing
- Botulinum Toxin Type A
- Where
- South Korea
- Volunteers
- 69 people
- Sponsor
- Medy-Tox